CTS ($CTS) posted quarterly earnings results for Q4 2025 on Tuesday, February 10th. The company reported earnings of $0.62 per share, beating estimates of $0.61 by $0.01. The company also reported revenue of $137,270,000, beating estimates of $137,214,560 by $55,440.
You can see Quiver Quantitative's $CTS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CTS Hedge Fund Activity
We have seen 131 institutional investors add shares of CTS stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,110,519 shares (-67.2%) from their portfolio in Q3 2025, for an estimated $44,354,128
- TRIBUTARY CAPITAL MANAGEMENT, LLC removed 260,722 shares (-49.3%) from their portfolio in Q4 2025, for an estimated $11,177,152
- HARVEY PARTNERS, LLC added 210,964 shares (+74.7%) to their portfolio in Q3 2025, for an estimated $8,425,902
- QUBE RESEARCH & TECHNOLOGIES LTD added 153,568 shares (+56.2%) to their portfolio in Q3 2025, for an estimated $6,133,505
- RENAISSANCE TECHNOLOGIES LLC added 141,484 shares (+66.6%) to their portfolio in Q3 2025, for an estimated $5,650,870
- BLACKROCK, INC. removed 108,306 shares (-2.4%) from their portfolio in Q3 2025, for an estimated $4,325,741
- EARNEST PARTNERS LLC removed 107,068 shares (-5.4%) from their portfolio in Q3 2025, for an estimated $4,276,295
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CTS Government Contracts
We have seen $330,000 of award payments to $CTS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.